69 Best Pharma Startups in Switzerland to Watch in 2024

Clinical-stage central nervous system (CNS) technology.

Total Raised: $169.29M

Last Funding: $110.29M (Series B)

Novel antiobiotic researcher to fight antimicrobial resistance.

Total Raised: $34.47M

Last Funding: $13.57M (Series C)

Anjarium is an early-stage biotechnology company developing next-generation, non-viral gene therapy therapeutics.

Total Raised: $59.53M

Last Funding: $59.53M (Series A)

Immunotherapy platform for cancer.

Total Raised: $93.33M

Last Funding: $74.00M (Unknown)

Biotechnology platform developing therapies by investing in people and ideas.

Total Raised: $25.31M

Last Funding: $0.00M (Unknown)

Platform for developing curative treatments for genetic diseases, blood cancers, and severe autoimmune disorders.

Total Raised: $50.00M

Last Funding: $50.00M (Series A)

Platform for observing live cells in 3D without damaging them.

Total Raised: $22.20M

Last Funding: $20.00M (Unknown)

Clinical stage developer focused on providing an oral treatment for patients using a bradykinin B2 receptor antagonist.

Total Raised: $80.00M

Last Funding: $80.00M (Series C)

Glycanengineering platform.

Total Raised: $49.29M

Last Funding: $49.29M (Series A)

Treatments that improve the lives of cancer patients with innovative approaches.

Total Raised: $26.73M

Last Funding: $26.73M (Series C)

Software platform that accelerates innovation in the pharmaceutical industry.

Total Raised: $12.70M

Last Funding: $12.70M (Seed)

Platform offering tools to enhance the development of personalized and precision medicine.

Total Raised: $35.31M

Last Funding: $20.31M (Unknown)

Clinical-stage biopharmaceutical company developing drugs for rare diseases.

Total Raised: $16.00M

Last Funding: $16.00M (Series A)

Tumor immunotherapy drug developer.

Total Raised: $7.00M

Last Funding: $7.00M (Seed)

We engineered the first injectable biomaterial that stimulated the body's natural ossification process for rapid bone repair & strengthening

Total Raised: $2.33M

Last Funding: $2.16M (Seed)

Immunosuppressive drugs manufacturer for autoimmune diseases and transplantations.

Total Raised: $3.90M

Last Funding: $3.90M (Pre Seed)

Bloom Biorenewables is making biomass a true alternative to petroleum.

Total Raised: $3.44M

Last Funding: $3.44M (Unknown)

Platform focusing on the discovery and development of next-generation RNA-based drugs.

Total Raised: $6.42M

Last Funding: $6.42M (Seed)

Platform that identifies the ideal treatment for each cancer patient’s disease.

Total Raised: $7.62M

Last Funding: $7.62M (Unknown)

Developer of oral therapeutics to treat complex autoimmune diseases.

Total Raised: $3.50M

Last Funding: $3.50M (Seed)

Self-testing kit provider for quick, at-home medical results.

Total Raised: $1.73M

Last Funding: $1.73M (Seed)

Biotechnology company developing treatments to enhance immune system responses.

Total Raised: $0.15M

Last Funding: $0.15M (Pre Seed)

Pharmaceutical manufacturing services for producing medications and therapies.

Total Raised: $0.81M

Last Funding: $0.81M (Seed)

Anti-cancer drug evaluator.

Total Raised: $0.17M

Last Funding: $0.17M (Pre Seed)

Developer of oral therapeutics to treat complex autoimmune diseases.

Clinical stage R&D company developing therapies to control and modulate pathogenic gene expression.

Last Funding: $0.00M (Unknown)

Learning platform for the pharma industry.